In brief
A 2026 study modeling trends out to 2050 projects cervical cancer cases will increase 20.2 % and deaths 39.3 %, reaching roughly 1.08 million cases and 522,000 deaths annually. The largest surge — nearly double in both incidence and mortality — is expected in sub‑Saharan Africa, where deaths could reach 206,000 by 2050. The study highlights that none of the world’s regions is likely to meet WHO’s elimination threshold without expanded vaccination, screening and treatment access.
In a modelling study released on November 3, 2026, Australian and international researchers forecast that global cervical cancer cases will rise by 20.2 percent and deaths by 39.3 percent by 2050, according to Xinhua reporting on the Australian Science Media Center website. The research, published in Nature Medicine, examined data from 1990 to 2023 across 204 countries and projected 1.08 million new cases and 522,000 deaths annually by 2050.
Sub‑Saharan Africa is projected to bear the heaviest burden, with cases rising 88.7 percent and deaths 95.4 percent, reaching an estimated 206,000 deaths in 2050, the study notes. In 2023, the age‑standardized incidence rate in low‑income countries was over four times higher than in high‑income countries, and the mortality rate over seven times higher.
None of the seven global regions studied is forecast to meet the World Health Organization’s cervical cancer elimination threshold of fewer than four cases per 100,000 women by 2050 if current trends persist. The authors call for broader access to human papillomavirus (HPV) vaccination, screening and treatment to reverse the projected trend.
The findings underscore the urgent need for intensified prevention and treatment efforts worldwide, particularly in low‑income regions where the disease’s preventability contrasts sharply with its rising impact.
